EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Deep Learning for Melanoma Detection: A Deep Learning Approach to Differentiating Malignant Melanoma from Benign Melanocytic Nevi

Magdalini Kreouzi, Nikolaos Theodorakis iD, Georgios Feretzakis iD, Evgenia Paxinou iD, Aikaterini Sakagianni iD, Dimitris Kalles iD, Athanasios Anastasiou iD, Vassilios S Verykios iD, Maria Nikolaou iD

Cancers · 25.12.2024 · 17 (1) · 28

DOI: 10.3390/cancers17010028 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 25.12.2024. Verfasst von Magdalini Kreouzi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine & 65+ Clinic, Amalia Fleming General Hospital, 14, 25th Martiou Str., 15127 Melissia, Greece. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Melanoma, an aggressive form of skin cancer, accounts for a significant proportion of skin-cancer-related deaths worldwide. Early and accurate differentiation between melanoma and benign melanocytic nevi is critical for improving survival rates but remains challenging because of diagnostic variability. Convolutional neural networks (CNNs) have shown promise in automating melanoma detection with accuracy comparable to expert dermatologists. This study evaluates and compares the performance of four CNN architectures—DenseNet121, ResNet50V2, NASNetMobile, and MobileNetV2—for the binary classification of dermoscopic images.

Methods

A dataset of 8825 dermoscopic images from DermNet was standardized and divided into training (80%), validation (10%), and testing (10%) subsets. Image augmentation techniques were applied to enhance model generalizability. The CNN architectures were pre-trained on ImageNet and customized for binary classification. Models were trained using the Adam optimizer and evaluated based on accuracy, area under the receiver operating characteristic curve (AUC-ROC), inference time, and model size. The statistical significance of the differences was assessed using McNemar’s test.

Results

DenseNet121 achieved the highest accuracy (92.30%) and an AUC of 0.951, while ResNet50V2 recorded the highest AUC (0.957). MobileNetV2 combined efficiency with competitive performance, achieving a 92.19% accuracy, the smallest model size (9.89 MB), and the fastest inference time (23.46 ms). NASNetMobile, despite its compact size, had a slower inference time (108.67 ms), and slightly lower accuracy (90.94%). Performance differences among the models were statistically significant (p < 0.0001).

Conclusions

DenseNet121 demonstrated a superior diagnostic performance, while MobileNetV2 provided the most efficient solution for deployment in resource-constrained settings. The CNNs show substantial potential for improving melanoma detection in clinical and mobile applications.

Schlagwörter

Stichwörter der Autor:innen

artificial intelligenceconvolutional neural networksdeep learning modelsdermoscopic imagesearly cancer detectionmedical imagingmelanoma detectionskin cancer diagnosis

Autor:innen und Institutionen

  • Department of Internal Medicine & 65+ Clinic, Amalia Fleming General Hospital, 14, 25th Martiou Str., 15127 Melissia, Greece.
  • NT-CardioMetabolics, Clinic for Metabolism and Athletic Performance, 47 Tirteou Str., 17564 Palaio Faliro, Greece.
  • 65+ Outpatient Clinic, Amalia Fleming General Hospital, 14, 25th Martiou Str., 15127 Melissia, Greece.
  • School of Medicine, National and Kapodistrian University of Athens, 75 Mikras Asias, 11527 Athens, Greece.
  • School of Science and Technology, Hellenic Open University, 18 Aristotelous Str., 26335 Patras, Greece.
  • Intensive Care Unit, Sismanogelio General Hospital, 37 Sismanogleiou Str., 15126 Marousi, Greece.

ORCID-Profile: Nikolaos Theodorakis, Georgios Feretzakis, Evgenia Paxinou, Aikaterini Sakagianni, Dimitris Kalles, Athanasios Anastasiou, Vassilios S Verykios, Maria Nikolaou

Zitieren

APA

Kreouzi, M., Theodorakis, N., Feretzakis, G., Paxinou, E., Sakagianni, A., Kalles, D., Anastasiou, A., Verykios, V. S., & Nikolaou, M. (2024). Deep Learning for Melanoma Detection: A Deep Learning Approach to Differentiating Malignant Melanoma from Benign Melanocytic Nevi. Cancers, 17(1), 28. https://doi.org/10.3390/cancers17010028

Vancouver

Kreouzi M, Theodorakis N, Feretzakis G, Paxinou E, Sakagianni A, Kalles D, et al. Deep Learning for Melanoma Detection: A Deep Learning Approach to Differentiating Malignant Melanoma from Benign Melanocytic Nevi. Cancers. 2024;17(1):28. doi:10.3390/cancers17010028

BibTeX
@article{Kreouzi2024,
  author = {Kreouzi, Magdalini and Theodorakis, Nikolaos and Feretzakis, Georgios and Paxinou, Evgenia and Sakagianni, Aikaterini and Kalles, Dimitris and Anastasiou, Athanasios and Verykios, Vassilios S and Nikolaou, Maria},
  title = {Deep Learning for Melanoma Detection: A Deep Learning Approach to Differentiating Malignant Melanoma from Benign Melanocytic Nevi},
  journal = {Cancers},
  year = {2024},
  volume = {17},
  number = {1},
  pages = {28},
  doi = {10.3390/cancers17010028}
}
Kostenlos starten →